T cell recognition of xeno-MHC peptides during concordant xenograft rejection

Transplantation

Volumn 61, Issue 8, 1996, Pages 1133-1137

  Murphy, Barbara ^a   Auchincloss Jr , Hugh ^b   Carpenter, Charles B ^a   Sayegh, Mohamed H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; XENOTRANSPLANTATION;

ANIMALS; ANTIGEN PRESENTATION; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; RATS; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029865973     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604270-00001     Document Type: Article

References (30)

1. Auchincloss HJ. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
2. Kaufman CL, Gaines BA, Ildstsd ST. Xenotransplantation. Annu Rev Immunol 1995; 13: 339.
3. Moses RD, Pierson RN, Winn HJ, Auchincloss H. Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cell and self antigen-presenting cells in the mouse. J Exp Med 1990; 172: 567.
4. Lucas PJ, Shearer GM, Neudorf S, Gress RE. The human anti-murine xenogeneic cytotoxic response. I. Dependence on responder antigen-presenting cells. J Immunol 1990; 144: 4548.
5. Alter BJ, Bach FH. Cellular basis of the proliferative response of human T cells to mouse xenoantigens. J Exp Med 1990; 171: 333.
6. Pierson RN, Winn HJ, Russell PS, Auchincloss H. Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med 1989; 170: 991.
7. Auchincloss H, Moses R, Conti D, et al. Xenograft rejection of class I-expressing transgeneic skin is CD4-dependent and CD8-independent. Transplant Proc 1990; 22: 2335.
8. Sayegh MH, Khoury SK, Hancock WW, Weiner HL, Carpenter CB. Induction of immunity and oral tolerance with polymorphic class II MHC allopeptides in the rat. Proc Natl Acad Sci USA 1992; 89: 7762.
9. Gallon L, Watschinger B, Murphy B, Akalin E, Sayegh MH, Carpenter CB. Indirect pathway of allorecognition: the occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute allograft rejection and its inhibition by conventional immunosuppression. Transplantation 1995; 59: 612.
10. Viguier M, Loteau V, Charron D, Debre P. Xenogeneic recognition of soluble and cell surface HLA class II antigens by proliferative murine T cells. Eur J Immunol 1987; 17: 1540.
11. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of Allorecognition: recognition by in vivo primed T-cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572.
12. Lance E, Medewar P. Survival of skin heterografts under treatment with antilymphocyte serum. Lancet 1968; 1: 1174.
13. Corry R, Winn H, Russell P. Primary vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
14. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenograft: a review of progress. Immunol Today 1990; 11: 450.
15. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995; 1: 423.
16. Leventhal JR, Matas AJ, Lin Hong Sun, et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993; 56: 1.
17. Blakely ML, Van Der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059.
18. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 1994; 57: 1295.
19. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
20. Moses RD, Winn HJ, Auchincloss H. Evidence that multiple defects in the cell-surface molecule interactions across species differences for diminished xenogeneic T cell responses. Transplantation 1992; 53: 203.
21. Woolnough JA, Misko IS, Lafferty KJ. Cytotoxic and proliferative lymphocyte responses to allogeneic and xenogeneic antigens in vitro. Aust J Exp Biol Med Sci 1979; 57: 467.
22. Widmer MB, Bach FH. Allogeneic and xenogeneic response in mixed leucocyte cultures. J Exp Med 1972; 135: 1204.
23. Yoshizawa K, Yano, A. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR. J Immunol 1984; 132: 2820.
24. Oluwole SF, Chowdhury NC, Jin M, Hardy MA. Induction of transplantation tolerance in rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides. Transplantation 1993; 56: 1523.
25. Oluwole SF, Jin M-X, Chowdhury NC, Ohajekwe OA. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression. Transplantation 1994; 58: 1077.
26. Qian T, Schachner R, Brendel M, Kong S, Alejandro R. Induction of donor specific tolerance to rat islet allografts by intrathymic inoculation of solubilized spleen cell membrane antigens. Diabetes 1993; 42: 1544.
27. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II MHC allopeptides induces donor specific unresponsiveness to renal allografts. Transplantation 1993; 56: 461.
28. Sayegh MH, Perico N, Gallon L, et al. Mechanisms of acquired thymic unresponsiveness to renal allografts: thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 1994; 58: 125.
29. Dengping Y, Fathman CG. CD4-positive suppressor cells block allotransplant rejection. J Immunol 1995; 154: 6339.
30. Sayegh M, Krensky A. Novel immunotherapeutic strategies using MHC derived peptides. Kidney Int 1996; 49: S13.